Stock 603079 ZHEJIANG SHENGDA BIO-PHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Shengda Bio-Pharm Co., Ltd.

Equities

603079

CNE100002W43

Food Processing

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
11.7 CNY +7.24% Intraday chart for Zhejiang Shengda Bio-Pharm Co., Ltd. +26.49% -19.70%
Apr. 19 Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 19 Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,808 4,460 3,698 2,962 2,148 2,486
Enterprise Value (EV) 1 1,637 4,443 3,247 2,584 1,860 2,398
P/E ratio 40.4 x 94.8 x 18.5 x 39.3 x 69.7 x -45.5 x
Yield 0.74% 0.3% 1.62% 0.81% 0.48% -
Capitalization / Revenue 3.67 x 8.59 x 4.26 x 3.75 x 2.91 x 3.42 x
EV / Revenue 3.32 x 8.56 x 3.74 x 3.27 x 2.52 x 3.3 x
EV / EBITDA 21 x 45.9 x 9.8 x 19.7 x 32.4 x 34.6 x
EV / FCF 123 x -25.1 x 24.9 x -58.6 x -33 x -17.1 x
FCF Yield 0.81% -3.98% 4.02% -1.71% -3.03% -5.86%
Price to Book 2.28 x 5.05 x 2.83 x 2.24 x 1.62 x 1.42 x
Nbr of stocks (in thousands) 156,800 156,800 171,189 171,189 171,189 170,657
Reference price 2 11.53 28.44 21.60 17.30 12.55 14.57
Announcement Date 3/18/19 4/27/20 4/12/21 4/28/22 3/24/23 4/19/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 492.7 519.1 867.3 789.7 738 727.4
EBITDA 1 78.11 96.81 331.3 131.3 57.43 69.3
EBIT 1 45.14 45.14 261.6 60.49 -10.07 -2.751
Operating Margin 9.16% 8.69% 30.16% 7.66% -1.36% -0.38%
Earnings before Tax (EBT) 1 52.4 49.18 223.7 80.04 36.52 -45.31
Net income 1 44.54 47.03 197.4 75.76 31.49 -54.06
Net margin 9.04% 9.06% 22.76% 9.59% 4.27% -7.43%
EPS 2 0.2857 0.2999 1.170 0.4400 0.1800 -0.3200
Free Cash Flow 1 13.33 -176.8 130.6 -44.12 -56.43 -140.6
FCF margin 2.7% -34.05% 15.06% -5.59% -7.65% -19.33%
FCF Conversion (EBITDA) 17.06% - 39.43% - - -
FCF Conversion (Net income) 29.92% - 66.16% - - -
Dividend per Share 2 0.0857 0.0857 0.3500 0.1400 0.0600 -
Announcement Date 3/18/19 4/27/20 4/12/21 4/28/22 3/24/23 4/19/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 171 16.7 450 378 288 88.3
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 13.3 -177 131 -44.1 -56.4 -141
ROE (net income / shareholders' equity) 5.33% 4.34% 17% 5.4% 2.27% -4.15%
ROA (Net income/ Total Assets) 2.52% 2.03% 10.1% 2.18% -0.37% -0.1%
Assets 1 1,767 2,322 1,952 3,473 -8,561 53,055
Book Value Per Share 2 5.050 5.640 7.620 7.710 7.760 10.20
Cash Flow per Share 2 1.920 2.090 2.690 3.010 1.870 2.640
Capex 1 145 186 85.2 100 63.3 246
Capex / Sales 29.33% 35.8% 9.82% 12.66% 8.57% 33.81%
Announcement Date 3/18/19 4/27/20 4/12/21 4/28/22 3/24/23 4/19/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
ZHEJIANG SHENGDA BIO-PHARM CO., LTD. Stock Zhejiang Shengda Bio-Pharm Co., Ltd.
-19.70% 255M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+11.32% 7.78B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+1.64% 7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+10.50% 6.52B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.69% 3.67B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-13.08% 3.44B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-10.10% 1.17B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+8.34% 934M
HERBALIFE LTD. Stock Herbalife Ltd.
-42.73% 879M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-19.59% 836M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. 603079 Stock
  4. Financials Zhejiang Shengda Bio-Pharm Co., Ltd.